CaNCURE Co-op Showcase
The CaNCURE Team would like to send out a congratulations to the 8 trainees who completed their CaNCURE co-op this December! We were so proud to see all your accomplishments at our second annual CaNCURE Co-op Showcase and to learn that for many of you, this co-op was a career-defining experience!
Ciprian Catana, M.D., Ph.D.
Associate Professor in Radiology , HMS
Our laboratory seeks to improve the quantification of the PET data using the simultaneously acquired MR information in integrated MR-PET scanners. Students will have the opportunity to use advanced MR-PET methods to study the delivery, mechanism of action and effects of therapeutic agents in cancer patients.
Bryan Spring, Ph.D.
Assistant Professor, NEU
The ultimate goal of the program is to reduce cancer recurrence and mortality by establishing new approaches for personalized medicine that address tumor heterogeneity, drug-resistance and molecular mechanisms of treatment escape. Advanced-stage cancer patients are presently subjected to a grueling treatment regimen consisting of surgical tumor debulking and high-dose-intensity chemotherapy. These standard approaches frequently hit a wall due to dose-limiting toxicities as well as mechanisms of drug-resistance and treatment escape via cell signaling networks.
Health Science, '18
The Assessment and Comparison of Ferumoxtran as Contrast Imaging Agent in Patients with Pancreatic Cancers.
Ann Marie Billig
Health Science, '18
miRNA analysis in mouse model of metastatic breast cancer. (Proj 2) The inhibition of PD-L1 on a Pan02 cell line w/ siRNA-nanodrug & gemcitabine treatment
Quantitative Multimodal Imaging of Tumor Response to Radiation
Going on in the lab right now...
Development of PSMA-targeting nanoparticles for positron emitting tomography imaging in prostate cancer using animal models
The project focuses on using the nanoparticle feraheme as a scaffold to include a PSMA-targeting inhibitor by click chemistry in order to target prostate cancer tumors in animal models.